Blood ozonization in patients with mild to moderate COVID-19 pneumonia: a single centre experience: reply.
作者信息
De Monte Amato, Sermann Giovanni, Sozio Emanuela, Sbrana Francesco, Tascini Carlo
机构信息
SOC Anestesia e Rianimazione Uno, Università di Udine e Azienda Sanitaria Universitaria Integrata Di Udine, Udine, Italia.
U.O. Malattie Infettive, Dipartimento di Medicina dell'Università di Udine, Università di Udine e Azienda Sanitaria Universitaria Integrata Di Udine, Udine, Italia.
出版信息
Intern Emerg Med. 2021 Apr;16(3):795-796. doi: 10.1007/s11739-021-02630-1. Epub 2021 Feb 3.
Abstract
摘要
相似文献
1
Blood ozonization in patients with mild to moderate COVID-19 pneumonia: a single centre experience: reply.轻度至中度新型冠状病毒肺炎患者的血液臭氧疗法：单中心经验：回复
Intern Emerg Med. 2021 Apr;16(3):795-796. doi: 10.1007/s11739-021-02630-1. Epub 2021 Feb 3.
2
Blood ozonization in patients with mild to moderate COVID-19 pneumonia: a single centre experience.轻度至中度 COVID-19 肺炎患者的血液臭氧疗法：单中心经验。
Intern Emerg Med. 2021 Apr;16(3):669-675. doi: 10.1007/s11739-020-02542-6. Epub 2020 Nov 1.
3
The need for a correct oxygen-ozone autohemotherapy (O-AHT) in patients with mild to moderate COVID-19 pneumonia.轻度至中度新冠肺炎患者对正确的氧-臭氧自血疗法（O-AHT）的需求。
Intern Emerg Med. 2021 Apr;16(3):793-794. doi: 10.1007/s11739-020-02592-w. Epub 2021 Jan 5.
4
Oxygen-ozone therapy as adjuvant in the current emergency in SARS-COV-2 infection: a clinical study.臭氧氧气疗法作为 SARS-CoV-2 感染急救治疗的辅助手段：一项临床研究。
J Biol Regul Homeost Agents. 2020 May-Jun;34(3):757-766. doi: 10.23812/20-250-E-56.
5
Potential Role of Oxygen-Ozone Therapy in Treatment of COVID-19 Pneumonia.氧-臭氧疗法在新冠肺炎治疗中的潜在作用
Am J Case Rep. 2020 Aug 17;21:e925849. doi: 10.12659/AJCR.925849.
6
Oxygen-ozone treatment and COVID-19: antioxidants targeting endothelia lead the scenery.臭氧治疗与新型冠状病毒肺炎：靶向内皮细胞的抗氧化剂成为焦点。
Intern Emerg Med. 2022 Mar;17(2):593-596. doi: 10.1007/s11739-021-02865-y. Epub 2021 Oct 22.
7
Potential mechanisms by which the oxygen-ozone (O2-O3) therapy could contribute to the treatment against the coronavirus COVID-19.氧-臭氧（O2-O3）疗法有助于治疗新型冠状病毒COVID-19的潜在机制。
Eur Rev Med Pharmacol Sci. 2020 Apr;24(8):4059-4061. doi: 10.26355/eurrev_202004_20976.
8
Oxygen-ozone (O-O) immunoceutical therapy for patients with COVID-19. Preliminary evidence reported.用于 COVID-19 患者的氧气-臭氧（O-O）免疫疗法。初步报告的证据。
Int Immunopharmacol. 2020 Nov;88:106879. doi: 10.1016/j.intimp.2020.106879. Epub 2020 Aug 8.
9
Oxygen-ozone autohemotherapy against COVID-19 needs to fit highly experienced, customized, and standardized protocols to succeed.采用臭氧自血疗法治疗新冠肺炎需要符合经验丰富、量身定制且标准化的方案才能取得成功。
J Med Virol. 2021 May;93(5):2580-2582. doi: 10.1002/jmv.26806. Epub 2021 Jan 27.
10
Profiling of T Cell Repertoire in SARS-CoV-2-Infected COVID-19 Patients Between Mild Disease and Pneumonia.SARS-CoV-2 感染 COVID-19 患者轻症与肺炎患者 T 细胞受体谱分析。
J Clin Immunol. 2021 Aug;41(6):1131-1145. doi: 10.1007/s10875-021-01045-z. Epub 2021 May 5.
引用本文的文献
1
Insights on the mechanisms of action of ozone in the medical therapy against COVID-19.关于臭氧在抗新冠病毒医学治疗中作用机制的见解。
Int Immunopharmacol. 2021 Jul;96:107777. doi: 10.1016/j.intimp.2021.107777. Epub 2021 May 11.
本文引用的文献
1
Ozone therapy for patients with COVID-19 pneumonia: Preliminary report of a prospective case-control study.新冠病毒肺炎患者的臭氧疗法：一项前瞻性病例对照研究的初步报告。
Int Immunopharmacol. 2021 Jan;90:107261. doi: 10.1016/j.intimp.2020.107261. Epub 2020 Dec 5.
2
Blood ozonization in patients with mild to moderate COVID-19 pneumonia: a single centre experience.轻度至中度 COVID-19 肺炎患者的血液臭氧疗法：单中心经验。
Intern Emerg Med. 2021 Apr;16(3):669-675. doi: 10.1007/s11739-020-02542-6. Epub 2020 Nov 1.
3
Oxygen-ozone (O-O) immunoceutical therapy for patients with COVID-19. Preliminary evidence reported.用于 COVID-19 患者的氧气-臭氧（O-O）免疫疗法。初步报告的证据。
Int Immunopharmacol. 2020 Nov;88:106879. doi: 10.1016/j.intimp.2020.106879. Epub 2020 Aug 8.
Zotero 插件